Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CYTOCHROME P450 CYP2C9' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 13 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Takahashi, H; Echizen, H
      Pharmacogenetics of warfarin elimination and its clinical implications

      CLINICAL PHARMACOKINETICS
    2. Tabrizi, AR; Freeman, BD; Buchman, TG; Zehnbauer, BA
      Genetic susceptibility to hemorrhagic complications during warfarin therapy

      SURGERY
    3. Garcia-Martin, E; Martinez, C; Ladero, JM; Gamito, FJG; Agundez, JAG
      High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    4. Morin, S; Loriot, MA; Poirier, JM; Tenneze, L; Beaune, PH; Funck-Brentano, C; Jaillon, P; Becquemont, L
      Is diclofenac a valuable CYP2C9 probe in humans?

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    5. Dickmann, LJ; Rettie, AE; Kneller, MB; Kim, RB; Wood, AJJ; Stein, CM; Wilkinson, GR; Schwarz, UI
      Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans

      MOLECULAR PHARMACOLOGY
    6. Thijssen, HHW; Drittij, MJ; Vervoort, LMT; de Vries-Hanje, JC
      Altered pharmacokinetics of R- and S-acenocoumarol in a subject heterozygous for CYP2C9*3

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    7. Loebstein, R; Yonath, H; Peleg, D; Almog, S; Rotenberg, M; Lubetsky, A; Roitelman, J; Harats, D; Halkin, H; Ezra, D
      Interindividual variability in sensitivity to warfarin - Nature or nurture?

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    8. Linder, MW
      Genetic mechanisms for hypersensitivity and resistance to the anticoagulant Warfarin

      CLINICA CHIMICA ACTA
    9. Thijssen, HHW; Verkooijen, IWC; Frank, HLL
      The possession of the CYP2C9*3 allele is associated with low dose requirement of acenocoumarol

      PHARMACOGENETICS
    10. Miners, JO; Coulter, S; Birkett, DJ; Goldstein, JA
      Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes

      PHARMACOGENETICS
    11. Broder, S; Venter, JC
      Sequencing the entire genomes of free-living organisms: The foundation of pharmacology in the new millennium

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    12. STUBBINS MJ; HARRIES LW; SMITH G; TARBIT MH; WOLF CR
      GENETIC-ANALYSIS OF THE HUMAN CYTOCHROME-P450 CYP2C9 LOCUS

      Pharmacogenetics
    13. TRANSON C; LECOEUR S; LEEMANN T; BEAUNE P; DAYER P
      INTERINDIVIDUAL VARIABILITY IN CATALYTIC ACTIVITY AND IMMUNOREACTIVITY OF 3 MAJOR HUMAN LIVER CYTOCHROME-P450 ISOZYMES

      European Journal of Clinical Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/02/20 alle ore 11:39:33